Optiver Holding’s AstraZeneca AZN Stock Holding History

Optiver Holding’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.1M	Sell	90,150 -5,283	-6%	-$994K	﹤0.01%	348
2026 Q1	$18.8M	Buy	+95,433	New	+$18.4M	0.01%	287
2025 Q4	–	Sell	-11,638	Closed	-$2.04M	–	2503
2025 Q3	$1.79M	Buy	+11,638	New	+$1.76M	﹤0.01%	405
2025 Q2	–	Sell	-276,006	Closed	-$38.7M	–	1465
2025 Q1	$40.6M	Buy	+276,006	New	+$39.9M	0.02%	106
2024 Q4	–	Sell	-112,175	Closed	-$15.7M	–	1045
2024 Q3	$17.5M	Sell	112,175 -35,638	-24%	-$5.75M	0.01%	194
2024 Q2	$23.1M	Buy	+147,813	New	+$22.2M	0.01%	202
2024 Q1	–	Sell	-540,495	Closed	-$71.6M	–	676
2023 Q4	$72.9M	Buy	540,495 +210,061	+64%	+$27.3M	0.04%	128
2023 Q3	$44.8M	Buy	330,434 +169,105	+105%	+$23.1M	0.03%	148
2023 Q2	$23.1M	Sell	161,329 -236,582	-59%	-$34.8M	0.02%	211
2023 Q1	$55.1M	Buy	397,911 +208,677	+110%	+$28.1M	0.04%	150
2022 Q4	$25.7M	Sell	189,234 -11,714	-6%	-$1.47M	0.03%	179
2022 Q3	$22.2M	Buy	+200,948	New	+$25.5M	0.02%	142
2022 Q2	–	Sell	-40,425	Closed	-$5.3M	–	370
2022 Q1	$5.36M	Sell	40,425 -386,613	-91%	-$46.4M	0.01%	163
2021 Q4	$49.8M	Buy	+427,038	New	+$50.2M	0.04%	96
2021 Q2	–	Sell	-380,807	Closed	-$41.8M	–	519
2021 Q1	$37.9M	Buy	+380,807	New	+$38.3M	0.06%	49

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Optiver Holding's AZN Position: Q2 2026 in Review

Optiver Holding reduced its AstraZeneca (AZN) stake by 5.5% in Q2 2026, selling an estimated $994K and leaving 90,150 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #348.

Optiver Holding first reported a position in AZN in Q1 2021 and has held it in 15 quarters since. The position peaked at $72.9M in Q4 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Optiver Holding held 90,150 shares of AstraZeneca worth $17.1M as of Q2 2026.
Optiver Holding sold 5,283 AstraZeneca shares in Q2 2026, an estimated $994K.
AstraZeneca made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #348 holding.
Optiver Holding first reported a position in AstraZeneca in Q1 2021 and has held it in 15 quarters since.
Optiver Holding's AstraZeneca position peaked at $72.9M in Q4 2023.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.